# \[e-med\] Accès aux médicaments et Propriété Intellectuelle : La contribution de l'OMS **URL:** \ **Category:** e-med\ **Created:** [May 13, 2013, 9:34am UTC](https://talk.edrugplus.org/t/e-med-acces-aux-medicaments-et-propriete-intellectuelle-la-contribution-de-loms/38933 "2013-05-13T09:34:21Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![c.bruneton](https://avatars.discourse-cdn.com/v4/letter/c/3ec8ea/32.png) [@c.bruneton](https://talk.edrugplus.org/u/c.bruneton)\ **Post date:** [May 13, 2013, 9:34am UTC](https://talk.edrugplus.org/t/e-med-acces-aux-medicaments-et-propriete-intellectuelle-la-contribution-de-loms/38933/1 "2013-05-13T09:34:21Z")
(Publication récente de German Velasquez qui est en anglais seulement.CB) Access to Medicines and Intellectual Property: The contribution of the World Health Organization Research Paper 47, May 2013 German Velasquez SOUTH CENTRE MAY 2013 [http://www.southcentre.org/index.php?option=com\_content&view=article&id=195](http://www.southcentre.org/index.php?option=com_content&view=article&id=195) 3%3Aaccess-to-medicines-and-intellectual-property-the-contribution-of-the-w orld-health-organization&catid=41%3Ainnovation-technology-and-patent-policy &Itemid=67&lang=en TABLE OF CONTENTS I. INTRODUCTION ........................................................................... .............................. 1 II. FIRST MANDATE OF THE WORLD HEALTH ASSEMBLY ............................................. 1 III. ³THE RED BOOK² ........................................................................... .......................... 2 IV. ORIGIN OF THE TERM TRIPS ³FLEXIBILITIES² ......................................................... 5 V. COMMISSION ON INTELLECTUAL PROPERTY RIGHTS, INNOVATION AND PUBLIC HEALTH (CIPIH) ........................................................................... ........................... 5 VI. THE GLOBAL STRATEGY AND PLAN OF ACTION ON PUBLIC HEALTH, INNOVATION AND INTELLECTUAL PROPERTY (GSPOA) ................................................................ 6 VII. CONSULTATIVE EXPERT WORKING GROUP ON RESEARCH AND DEVELOPMENT: FINANCING AND COORDINATION (CEWG) ..................................... 8 VIII. ADVANCES IN THE IMPLEMENTATION OF A ³GLOBAL STRATEGY² ........................... 9 IX. A STEP BACKWARDS FOR THE WHO? ...................................................................... 11 X. THE WAY FORWARDŠ ........................................................................... ................. 14 ANNEX I - RELEVANT WORLD HEALTH ASSEMBLY RESOLUTIONS ...................................... 15 ANNEX II - WHO PUBLICATIONS ON INTELLECTUAL PROPERTY AND PUBLIC HEALTH ....... 16 ANNEX III - IMPROVING ACCESS TO MEDICINES IN THAILAND: THE USE OF TRIPS FLEXIBILITIES: Report of a WHO Mission, Bangkok, 31 January to 6 February 2008 ................. 19